In cisplatin-resistant NSCLC cells, cerulenin reduced the metastatic potential by targeting the EMT regulated by FASN, without any impact on tumour growth, which was confirmed in an orthotropic model [67]. This evidence concerns the gene FASN and non-small cell lung carcinoma.